nsc 65346 has been researched along with pyrazolanthrone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jung, M; Lee, SA | 1 |
1 other study(ies) available for nsc 65346 and pyrazolanthrone
Article | Year |
---|---|
The nucleoside analog sangivamycin induces apoptotic cell death in breast carcinoma MCF7/adriamycin-resistant cells via protein kinase Cdelta and JNK activation.
Topics: Anthracenes; Antibiotics, Antineoplastic; Apoptosis; Breast Neoplasms; Caspases; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Activation; Enzyme Inhibitors; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Leukemic; Humans; JNK Mitogen-Activated Protein Kinases; Lamin Type A; MAP Kinase Kinase 4; Neoplasm Proteins; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protein Kinase C-delta; Protein Processing, Post-Translational; Pyrimidine Nucleosides | 2007 |